52 Week Range
As of on the Johannesburg Stock Exchange ∙ Minimum 15 minute delay
3M AVG Volume
52 Week High
52 Week Low
Shares Out (MIL)
Market Cap (MIL)
Dividend (Yield %)
Aspen Announces Deal With J&J To Make COVID-19 Vaccine
Aspen Pharmacare Updates On Divestment Of European Thrombosis Business To Mylan
Aspen Pharmacare Posts FY Normalised HEPS From Cont Ops Of 1464,6 CENTS
Aspen Pharmacare Holdings Limited is a South Africa-based supplier and manufacturer of branded and generic pharmaceutical products, as well as infant nutritional and consumer healthcare products. The Company's segments include International, South Africa, Asia Pacific and Sub-Saharan Africa (SSA). Its International business includes operating subsidiaries in Europe, Commonwealth of Independent States (CIS), Latin America, the Middle East and North Africa, Canada, as well as Mauritius-based Aspen Global Incorporated. The South African business provides branded, generic, over-the-counter, consumer health and infant nutritional products, which are supplied to pharmacies, retail pharmacy chains, hospitals, clinics, prescribing specialists, dispensing general practitioners, managed healthcare funders and retail stores across the private and public sectors in South Africa. Its business in Asia Pacific includes operations in Australasia, the Philippines, Taiwan and Japan.
Biotechnology & Drugs
Kuseni Douglas Dlamini
Independent Non-Executive Chairman of the Board
Stephen Bradley Saad
Group Chief Executive, Executive Director
Michael Guy Attridge
Deputy Group Chief Executive Officer, Finance Director, Executive Director
Group Finance Officer
Chief Executive Officer, Aspen Global Inc
Price To Earnings (TTM)
Price To Sales (TTM)
Price To Book (MRQ)
Price To Cash Flow (TTM)
Total Debt To Equity (MRQ)
LT Debt To Equity (MRQ)
Return on Investment (TTM)
Return on Equity (TTM)
South African pharmaceutical company Aspen Pharmacare <APNJ.J> said on Monday it had reached a preliminary agreement with Johnson & Johnson <JNJ.N> to commercially manufacture its COVID-19 vaccine candidate, sending its shares higher.
South African pharmaceutical major Aspen Pharmacare Holdings Ltd said on Thursday it is planning to expand its portfolio in emerging markets through a mix of organic growth and acquisitions, as part of a new strategy.
South African drugmaker Aspen Pharmacare has agreed to sell the rights to its European thrombosis business to U.S. pharmaceutical company Mylan for almost 642 million euros ($759 million), sending its shares up 7% on Tuesday.
Aspen <APNJ.J> has offered to cut prices by an average of 73% for six off-patent cancer drugs, EU antitrust regulators said on Tuesday, a move that could help the South African pharmaceutical company avoid a potentially hefty fine.
* CMA LEVIES FINES OF £2.3M AND SECURES £8M FOR NHS IN PHARMA PROBE
* JSE: APN - COMPLETION OF UNITED KINGDOM COMPETITION AUTHORITY INVESTIGATION
South African pharmaceutical major Aspen could provide 10 million dexamethasone tablets within a month, Chief Executive Stephen Saad said on Tuesday after the World Health Organisation cautioned about the drug's supply.
South African pharmaceutical maker Aspen could provide 10 million dexamethasone tablets within a month, CEO Stephen Saad told Reuters on Tuesday.
South Africa's pharmaceutical giant Aspen Pharmacare Holdings Ltd said on Monday the company had sufficient local capacity to produce injections to meet any demand surge for dexamethasone.
* USE OF DEXAMETHASONE IN THE CLINICAL MANAGEMENT OF PATIENTS WITH COVID-19 REQUIRING RESPIRATORY INTERVENTION
South Africa's Aspen Pharmacare Holdings Limited on Friday maintained its profit forecast for the year and said it was comfortable with its liquidity position amid uncertainties stemming from the novel coronavirus outbreak.
Aspen Pharmacare Holdings Limited on Friday maintained its profit forecast for the year and said it was comfortable with its liquidity position, amid uncertainties stemming from the novel coronavirus outbreak.
* STRATEGIC REVIEW AND INTERNAL RESTRUCTURING UNDERTAKEN IN RESPECT OF EUROPE CIS BUSINESS HAS BEEN ONGOING
The deputy chief executive of South Africa's Aspen Pharmacare said on Friday the drugmaker sees no immediate impact of India's decision this week to restrict the export of 26 pharmaceutical ingredients due to the coronavirus outbreak.
South African drugmaker Aspen Pharmacare Holdings Ltd <APNJ.J> reported a small rise in earnings in the first half of the 2020 financial year on Thursday and said the coronavirus outbreak would impact its performance.
South Africa's Aspen Pharmacare Holdings Ltd reported a marginal rise in half-year normalised earnings on Thursday as the drugmaker's manufacturing unit benefited from the restart of heparin sales to third party customers.
* JSE: APN - UNAUDITED GROUP FINANCIAL RESULTS FOR THE SIX MONTHS ENDED 31 DECEMBER 2019
South Africa's Aspen Pharmacare Holdings Ltd said on Friday it expects to report half-year results slightly above its forecast as the drugmaker's manufacturing unit benefited from the restart of heparin sales to third party customers.
* ASPEN PHARMACARE HOLDINGS LTD - RESULTS OF GROUP FOR SIX MONTHS ENDED 31 DECEMBER 2019 ARE SLIGHTLY AHEAD OF GUIDANCE
Novartis <NOVN.S> is buying the Japanese generics unit of South Africa's Aspen Pharmacare <APNJ.J> in a deal worth up to 400 million euros ($440.80 million) to expand in the world's third-biggest drug market, the Swiss drugmaker said on Monday.
Quote and financial data from Refinitiv. Fund performance data provided by Lipper. All quotes delayed a minimum of 15 minutes.